Orrick Tech Companies Team Advises Cortexyme in $76 Million Series B Financing

June.06.2018

Orrick has advised Cortexyme on its $76 million Series B financing round. San-Francisco based Cortexyme is a clinical-stage pharmaceutical company developing therapeutics to alter the course of Alzheimer’s and other degenerative diseases.

Orrick has been advising Cortexyme since its Series A financing and continues to counsel the company on various aspects of its business, including on corporate and trademark matters.

The Orrick team was led by Tech Companies Group partner Scott Iyama and included associates Laura Bloxham and Brigid McCurdy.

For additional information on the financing, please see Cortexyme’s press release.

Related Lawyers

Scott M. Iyama Partner, Technology Companies Group, Life Sciences

Silicon Valley; San Francisco

See my bio

D:+1 650 614 7637
E: [email protected]

Practice:

Technology & Innovation Sector
Technology Companies Group
Life Sciences

vCard

See full bio

Scott M. Iyama Partner

Silicon Valley; San Francisco

Scott leverages his technical experience as a member of research teams at Genentech (Virology R&D) and the NASA Ames Research Center (Advanced Displays Lab) to provide a unique business and legal perspective to companies commercializing disruptive solutions in technology and healthcare. In recognition for such work, The Recorder named Scott one of its “Lawyers on the Fast Track.”

Scott has represented a majority of such companies from inception, with many of the companies founded by leading entrepreneurs and scientists at University of California, Stanford University and Harvard University. He also works with non-profit entities, including the Ronald McDonald House Charities of the Bay Area. Scott’s practice has included representation of numerous high growth companies, including:

Technology

Facebook
Instagram
Nervana Systems
Planet Labs
ResearchGate

Life Science/Healthcare

Cortexyme
CyberHeart
EpiBone
GRO Bioscience
Virta Health

Stemming from his experience and deep knowledge in the life sciences and technology industries, Scott is a frequently sought after advisor, speaker and author on technology companies. He routinely volunteers his time with entrepreneur groups and frequently lectures at forums such as the National Cancer Institute, Stanford School of Medicine, Stanford University, Stanford Technology Venture Program, the University of California, Los Angeles and the California Life Sciences Association.

Related Areas

Markets

Bay Area: San Francisco and Silicon Valley